Health AI Central
Share:
Peer-Reviewed Publication
Am J Manag Care2024;30(9 Spec No.):SP722-SP724.August 1, 2024Journal Article

Cancer drugs speed to accelerated approvals, then hit the brakes in timely, clinically beneficial confirmatory trials.

Terra Wonsettler1
1Evolent.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.